Pollard RB[au] - Search Results

Year	Number of Results
1973	1
1975	3
1976	2
1977	1
1978	7
1979	2
1980	5
1981	4
1982	7
1984	1
1985	4
1986	6
1987	3
1988	4
1989	2
1990	6
1991	3
1992	9
1993	8
1994	10
1995	8
1996	9
1997	8
1998	7
1999	10
2000	7
2001	10
2002	13
2003	7
2004	7
2005	8
2006	7
2007	3
2008	6
2009	8
2010	7
2011	4
2012	7
2013	6
2014	3
2015	2
2016	3
2017	3
2018	1
2019	1
2022	0

1

Treatments for hepatitis B.

Asmuth DM, Nguyen HH, Melcher GP, Cohen SH, Pollard RB. Asmuth DM, et al. Among authors: pollard rb. Clin Infect Dis. 2004 Nov 1;39(9):1353-62. doi: 10.1086/425010. Epub 2004 Oct 12. Clin Infect Dis. 2004. PMID: 15494913 Review.

2

Peginterferon α-2a for the treatment of HIV infection.

Asmuth DM, Utay NS, Pollard RB. Asmuth DM, et al. Among authors: pollard rb. Expert Opin Investig Drugs. 2016;25(2):249-57. doi: 10.1517/13543784.2016.1132699. Epub 2016 Jan 4. Expert Opin Investig Drugs. 2016. PMID: 26667398 Review.

3

Immunotherapy of CMV infections.

Paar DP, Pollard RB. Paar DP, et al. Among authors: pollard rb. Adv Exp Med Biol. 1996;394:145-51. doi: 10.1007/978-1-4757-9209-6_15. Adv Exp Med Biol. 1996. PMID: 8815681 Review.

4

Didanosine once daily: potential for expanded use.

Pollard RB. Pollard RB. AIDS. 2000 Nov 10;14(16):2421-8. doi: 10.1097/00002030-200011100-00002. AIDS. 2000. PMID: 11101051 Review.

5

Toxicity of vidarabine.

Sacks SL, Smith JL, Pollard RB, Sawhney V, Mahol AS, Gregory P, Merigan TC, Robinson WS. Sacks SL, et al. Among authors: pollard rb. JAMA. 1979 Jan 5;241(1):28-9. doi: 10.1001/jama.1979.03290270020010. JAMA. 1979. PMID: 758490 No abstract available.

6

Safety profile of nevirapine, a nonnucleoside reverse transcriptase inhibitor for the treatment of human immunodeficiency virus infection.

Pollard RB, Robinson P, Dransfield K. Pollard RB, et al. Clin Ther. 1998 Nov-Dec;20(6):1071-92. doi: 10.1016/s0149-2918(98)80105-7. Clin Ther. 1998. PMID: 9916603 Review.

7

Associations of Plasma Cytokine and Microbial Translocation Biomarkers With Immune Reconstitution Inflammatory Syndrome.

George V, Harrison L, Roach M, Li XD, Tierney C, Fischl MA, Aberg J, Tebas P, Asmuth DM, Pollard RB, Godfrey C, Pahwa S; AIDS Clinical Trials Group A5202 Study Team. George V, et al. Among authors: pollard rb. J Infect Dis. 2017 Nov 27;216(9):1159-1163. doi: 10.1093/infdis/jix460. J Infect Dis. 2017. PMID: 29040604 Free PMC article.

8

Delayed gastrointestinal-associated lymphoid tissue reconstitution in duodenum compared with rectum in HIV-infected patients initiating antiretroviral therapy.

Sainz T, Serrano-Villar S, Mann S, Ma ZM, Utay NS, Thompson CG, Chun TW, Kashuba AD, Siewe B, Albanese A, Troia-Cancio P, Sinclair E, Somasunderam A, Yotter T, Moreno S, Pollard RB, Landay A, Miller CJ, Asmuth DM. Sainz T, et al. Among authors: pollard rb. AIDS. 2019 Dec 1;33(15):2289-2298. doi: 10.1097/QAD.0000000000002361. AIDS. 2019. PMID: 31764094 Free PMC article. Clinical Trial.

9

Hydroxypropyl-Beta-Cyclodextrin Reduces Inflammatory Signaling from Monocytes: Possible Implications for Suppression of HIV Chronic Immune Activation.

Matassoli FL, Leão IC, Bezerra BB, Pollard RB, Lütjohann D, Hildreth JEK, Arruda LB. Matassoli FL, et al. Among authors: pollard rb. mSphere. 2018 Nov 7;3(6):e00497-18. doi: 10.1128/mSphere.00497-18. mSphere. 2018. PMID: 30404938 Free PMC article.

10

Transforming growth factor-beta in the regulation of the immune response.

Sasaki H, Pollard RB, Schmitt D, Suzuki F. Sasaki H, et al. Among authors: pollard rb. Clin Immunol Immunopathol. 1992 Oct;65(1):1-9. doi: 10.1016/0090-1229(92)90241-f. Clin Immunol Immunopathol. 1992. PMID: 1395120 Review. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results